Screener
Prime Medicine PRME Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Prime Medicine’s reported figures.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
FAQ
- What is Prime Medicine's enterprise value?
- Prime Medicine (PRME) reported enterprise value of $717.81M in Q2 2026.
- How has Prime Medicine's enterprise value changed year-over-year?
- Prime Medicine's enterprise value increased by 113.7% year-over-year, from $335.84M to $717.81M.
- What is the long-term trend for Prime Medicine's enterprise value?
- Over 3 years (2022 to 2025), Prime Medicine's enterprise value has grown at a -18.0% compound annual growth rate (CAGR), from $1.21B to $666.08M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Prime Medicine's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude